Genomictree Inc. (KOSDAQ:228760)
27,700
0.00 (0.00%)
At close: Dec 5, 2025
Genomictree Revenue
Genomictree had revenue of 896.83M KRW in the quarter ending September 30, 2025, with 29.34% growth. This brings the company's revenue in the last twelve months to 3.76B, up 70.89% year-over-year. In the year 2024, Genomictree had annual revenue of 2.36B, down -30.89%.
Revenue (ttm)
3.76B
Revenue Growth
+70.89%
P/S Ratio
177.02
Revenue / Employee
n/a
Employees
77
Market Cap
665.42B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |